[Treatment of febrile episodes in the neutropenic subject: use of the combination of amikacin-colistin-trimethoprim-sulphamethoxazole].
D000380:Agranulocytosis / Q000188:drug therapy*; D000583:Amikacin / Q000627:therapeutic use*; D003091:Colistin / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005334:Fever / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007612:Kanamycin / Q000031:analogs & derivatives*; D009503:Neutropenia / Q000150:complications / Q000188:drug therapy*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use*
D007612:Kanamycin; D000583:Amikacin; D014295:Trimethoprim; D013420:Sulfamethoxazole; D003091:Colistin
Traitement des épisodes fébriles chez le sujet neutropénique. Utilisation de l'association amikacine-colistine-triméthoprime sulfaméthoxazole.